T
Tomas Hala
Researcher at Charles University in Prague
Publications - 2
Citations - 603
Tomas Hala is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Internal medicine & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 551 citations.
Papers
More filters
Journal ArticleDOI
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
Dirk J. Blom,Tomas Hala,Michael A. Bolognese,Michael J. Lillestol,Phillip D. Toth,Lesley J. Burgess,Richard Ceska,Eli M. Roth,Michael J. Koren,Christie M. Ballantyne,Maria Laura Monsalvo,Kate Tsirtsonis,Jae B. Kim,Robert A. Scott,Scott M. Wasserman,Evan A. Stein +15 more
TL;DR: At 52 weeks, evolocumab added to diet alone, to low-dose atorvastatin, or to high- dose atorVastatin with or without ezetimibe significantly reduced LDL cholesterol levels in patients with a range of cardiovascular risks.
Journal ArticleDOI
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK).
Cindy Weinstein,P. Sliwinska‐Stanczyk,Tomas Hala,Marina Stanislav,A. Tzontcheva,R. Yao,Yuliya Berd,Sean P. Curtis,George Phillip +8 more
TL;DR: The GO-BACK study as discussed by the authors evaluated the efficacy and safety of golimumab (GLM) treatment withdrawal in adults with non-radiographic axial spondyloarthritis (nr-axSpA) who demonstrate inactive disease during a 10-month open-label (OL) GLM run-in.